.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.aubrey: but with two young children and a busy schedule, she's come to appreciate the frozen food aisle. .
advertisement
.[email protected]
.